Literature DB >> 20878485

An exploration of the communication preferences regarding genetic testing in individuals from families with identified breast/ovarian cancer mutations.

Paboda Ratnayake1, Claire E Wakefield, Bettina Meiser, Graeme Suthers, Melanie A Price, Jessica Duffy, Kathy Tucker.   

Abstract

The responsibility for informing at-risk relatives of the availability of genetic testing for breast/ovarian cancer gene (BRCA1 or BRCA2) mutations currently falls on the probands. This study explored the support needs of individuals from families with identified BRCA1 or BRCA2 mutations when communicating about genetic risk and genetic testing with at-risk family members. Thirty-nine semi-structured telephone interviews were conducted with individuals from families with identified BRCA mutations. Interview responses were cross-tabulated by sample characteristics using the qualitative research analysis software NVivo8. The development of educational materials, which individuals could use when communicating the risks of carrying a BRCA gene mutation with their relatives, was identified as a specific need. Many participants expressed a preference for a staged approach, where relatives are notified of their increased risk and the availability of genetic testing risk either face-to-face or via a letter, with additional educational sources, including brief written information or access to a website, made available for those wishing to access more in-depth information. This research identified a need for the development of educational/informational resources to support individuals with identified breast/ovarian cancer mutations to communicate with their at-risk relatives about genetic risk and genetic testing availability.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20878485     DOI: 10.1007/s10689-010-9383-0

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  25 in total

1.  Communicating genetic test results to the family: a six-step, skills-building strategy.

Authors:  M B Daly; A Barsevick; S M Miller; R Buckman; J Costalas; S Montgomery; R Bingler
Journal:  Fam Community Health       Date:  2001-10

2.  Balancing autonomy and responsibility: the ethics of generating and disclosing genetic information.

Authors:  N Hallowell; C Foster; R Eeles; A Ardern-Jones; V Murday; M Watson
Journal:  J Med Ethics       Date:  2003-04       Impact factor: 2.903

3.  Recruiting patients to medical research: double blind randomised trial of "opt-in" versus "opt-out" strategies.

Authors:  Cornelia Junghans; Gene Feder; Harry Hemingway; Adam Timmis; Melvyn Jones
Journal:  BMJ       Date:  2005-09-12

Review 4.  Ethics, policy, and educational issues in genetic testing.

Authors:  Janet K Williams; Heather Skirton; Agnes Masny
Journal:  J Nurs Scholarsh       Date:  2006       Impact factor: 3.176

5.  Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients.

Authors:  Erna Claes; Gerry Evers-Kiebooms; Andrea Boogaerts; Marleen Decruyenaere; Lieve Denayer; Eric Legius
Journal:  Am J Med Genet A       Date:  2003-01-01       Impact factor: 2.802

6.  A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk.

Authors:  Claire E Wakefield; Bettina Meiser; Judi Homewood; Michelle Peate; Alan Taylor; Elizabeth Lobb; Judy Kirk; Mary-Anne Young; Rachel Williams; Tracy Dudding; Kathy Tucker
Journal:  Breast Cancer Res Treat       Date:  2007-02-27       Impact factor: 4.872

7.  Intention to communicate BRCA1/BRCA2 genetic test results to the family.

Authors:  Andrea M Barsevick; Susan V Montgomery; Karen Ruth; Eric A Ross; Brian L Egleston; Ruth Bingler; John Malick; Suzanne M Miller; Terrence P Cescon; Mary B Daly
Journal:  J Fam Psychol       Date:  2008-04

8.  An investigation of the disclosure process and support needs of BRCA1 and BRCA2 carriers.

Authors:  Jordana Segal; Mary Jane Esplen; Brenda Toner; Sylvia Baedorf; Steven Narod; Kate Butler
Journal:  Am J Med Genet A       Date:  2004-03-15       Impact factor: 2.802

Review 9.  Guidelines for disclosing genetic information to family members: from development to use.

Authors:  Béatrice Godard; Thierry Hurlimann; Martin Letendre; Nathalie Egalité
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

10.  Increased genetic counseling support improves communication of genetic information in families.

Authors:  Laura E Forrest; Jo Burke; Sonya Bacic; David J Amor
Journal:  Genet Med       Date:  2008-03       Impact factor: 8.822

View more
  12 in total

1.  The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice.

Authors:  Fred H Menko; Jacqueline A Ter Stege; Lizet E van der Kolk; Kiki N Jeanson; Winnie Schats; Daoud Ait Moha; Eveline M A Bleiker
Journal:  Fam Cancer       Date:  2019-01       Impact factor: 2.375

2.  Family communication following BRCA1/2 genetic testing: a close look at the process.

Authors:  Darquise Lafrenière; Karine Bouchard; Béatrice Godard; Jacques Simard; Michel Dorval
Journal:  J Genet Couns       Date:  2012-12-16       Impact factor: 2.537

3.  Communication about Congenital Adrenal Hyperplasia: Perspective of Filipino Families.

Authors:  Peter James B Abad; Cora A Anonuevo; Sandra Daack-Hirsch; Lorna R Abad; Carmencita D Padilla; Mercy Y Laurino
Journal:  J Genet Couns       Date:  2016-11-10       Impact factor: 2.537

4.  Communicating with Daughters About Familial Risk of Breast Cancer: Individual, Family, and Provider Influences on Women's Knowledge of Cancer Risk.

Authors:  Lucy A Peipins; Juan L Rodriguez; Nikki A Hawkins; Ashwini Soman; Mary C White; M Elizabeth Hodgson; Lisa A DeRoo; Dale P Sandler
Journal:  J Womens Health (Larchmt)       Date:  2018-01-29       Impact factor: 2.681

5.  Development and Pilot Testing of a Decision Aid for Genomic Research Participants Notified of Clinically Actionable Research Findings for Cancer Risk.

Authors:  Amanda M Willis; Sian K Smith; Bettina Meiser; Mandy L Ballinger; David M Thomas; Martin Tattersall; Mary-Anne Young
Journal:  J Genet Couns       Date:  2018-02-17       Impact factor: 2.537

6.  Family communication of BRCA1/2 results and family uptake of BRCA1/2 testing in a diverse population of BRCA1/2 carriers.

Authors:  Julia Fehniger; Feng Lin; Mary S Beattie; Galen Joseph; Celia Kaplan
Journal:  J Genet Couns       Date:  2013-05-12       Impact factor: 2.537

7.  Family communication in a population at risk for hypertrophic cardiomyopathy.

Authors:  Brittany Batte; Jane P Sheldon; Patricia Arscott; Darcy J Huismann; Lisa Salberg; Sharlene M Day; Beverly M Yashar
Journal:  J Genet Couns       Date:  2014-10-12       Impact factor: 2.537

8.  Quantifying family dissemination and identifying barriers to communication of risk information in Australian BRCA families.

Authors:  Emma Healey; Natalie Taylor; Sian Greening; Claire E Wakefield; Linda Warwick; Rachel Williams; Kathy Tucker
Journal:  Genet Med       Date:  2017-05-11       Impact factor: 8.822

9.  Disclosure of research results: a randomized study on GENEPSO-PS cohort participants.

Authors:  Julien Mancini; Elodie Le Cozannet; Anne-Déborah Bouhnik; Noémie Resseguier; Christine Lasset; Emmanuelle Mouret-Fourme; Catherine Noguès; Claire Julian-Reynier
Journal:  Health Expect       Date:  2015-07-23       Impact factor: 3.377

10.  Informing relatives about their hereditary or familial cancer risk: study protocol for a randomized controlled trial.

Authors:  Eveline de Geus; Cora M Aalfs; Mathilde G E Verdam; Hanneke C J M de Haes; Ellen M A Smets
Journal:  Trials       Date:  2014-03-20       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.